MERLI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 939
EU - Europa 296
AS - Asia 229
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 1.479
Nazione #
US - Stati Uniti d'America 934
SG - Singapore 120
IT - Italia 112
IE - Irlanda 68
CN - Cina 60
SE - Svezia 44
DE - Germania 18
IN - India 17
FR - Francia 11
FI - Finlandia 10
NG - Nigeria 8
BE - Belgio 7
JP - Giappone 7
KR - Corea 7
ID - Indonesia 6
UA - Ucraina 6
NL - Olanda 5
EU - Europa 4
GB - Regno Unito 4
IR - Iran 4
CA - Canada 3
MY - Malesia 3
AT - Austria 2
EG - Egitto 2
MX - Messico 2
PK - Pakistan 2
RS - Serbia 2
RU - Federazione Russa 2
SI - Slovenia 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
RO - Romania 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.479
Città #
Chandler 293
Singapore 103
Santa Clara 82
Dublin 68
Ashburn 50
Nyköping 35
Columbus 27
Turin 27
Council Bluffs 23
Princeton 22
Boston 16
Medford 16
Fairfield 15
Hebei 15
Milan 14
Beijing 12
New York 10
Pune 10
Torino 9
Abuja 8
Ann Arbor 8
Brussels 7
Hangzhou 7
Wilmington 7
Helsinki 6
Jakarta 6
Seoul 6
Cambridge 5
Chengdu 5
Guangzhou 5
Norwalk 5
Bari 4
Hamburg 4
Lappeenranta 4
Nellore 4
Parma 4
Seattle 4
Washington 4
Castiglione Olona 3
Chennai 3
Los Angeles 3
Redmond 3
San Diego 3
Valmacca 3
Woodbridge 3
Alexandria 2
Belgrade 2
Esslingen am Neckar 2
Guiyang 2
Houston 2
Karachi 2
La Paz 2
Ljubljana 2
London 2
L’Aquila 2
Mountain View 2
Munich 2
Naples 2
Perugia 2
Pescara 2
Putrajaya 2
Redwood City 2
Rome 2
Schwerin 2
Torre Pellice 2
Bologna 1
Brno 1
Caselle Torinese 1
Cattolica 1
Clearwater 1
Cologne 1
Denizli 1
Fagnano Olona 1
Falls Church 1
Frederick 1
Gainesville 1
Galati 1
Grugliasco 1
Gunzenhausen 1
Hefei 1
Henderson 1
Kajang 1
Kawasaki 1
Moscow 1
Osaka 1
Ottawa 1
Provo 1
Québec 1
Renens 1
Riverton 1
San Francisco 1
San Mauro Torinese 1
Shenyang 1
Stockholm 1
Stuttgart 1
Taipei 1
Tehran 1
Toronto 1
Upper Marlboro 1
Totale 1.045
Nome #
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 128
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 86
Immunotherapy in transplanted patients: A special population that can no longer be ignored 76
Familial melanoma and susceptibility genes: A review of the most common clinical and dermoscopic phenotypic aspect, associated malignancies and practical tips for management 72
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 65
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology 64
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 64
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report 63
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 60
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy 60
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 59
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study 57
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 57
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 56
Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al 55
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 55
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 53
Tocilizumab and its usage for skin diseases 51
Ruta graveolens phytophotodermatìtis 50
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 49
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 45
Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature 42
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 29
Perspectives of immunotherapy in non-melanoma skin cancers 28
A case of treatment-refractory psoriasis as the first manifestation of an HIV-infection 19
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome 17
A noma case report: A warning message from Northern Uganda 15
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course 15
Comparison of response between adults and adolescents in patients with severe atopic dermatitis treated with dupilumab 14
Anti-IL23 in inflammatory bowel disease patients with dermatological indication: The shared gastroenterological-dermatological clinic experience 12
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience 10
Totale 1.526
Categoria #
all - tutte 7.430
article - articoli 0
book - libri 0
conference - conferenze 465
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 1 2 0 0 0 0 0 0 0 2 4
2021/2022322 39 7 7 11 45 21 15 8 18 15 57 79
2022/2023593 50 95 11 83 56 111 34 35 59 11 30 18
2023/2024301 29 42 19 26 18 69 4 23 0 28 20 23
2024/2025301 16 39 29 71 146 0 0 0 0 0 0 0
Totale 1.526